Journal article : Letter

A matching‐adjusted indirect comparison of survival outcomes with pirtobrutinib ( BRUIN ) versus standard of care ( SCHOLAR ‐2) in relapsed/refractory mantle cell lymphoma previously treated with a covalent Bruton tyrosine kinase inhibitor

Publication status:: Published

Actions

Email

Email this record

Send the bibliographic details of this record to your email address.

Your Email
Please enter the email address that the record information will be sent to.

-
Your message (optional)
Please add any additional information to be included within the email.
Share
Cite

Cite this record

APA Style

Heß, G., Eyre, T. A., Jen, M., Zhang, J., Goebel, B., Abhyankar, S., & Dreyling, M. (2025). A matching‐adjusted indirect comparison of survival outcomes with pirtobrutinib ( BRUIN ) versus standard of care ( SCHOLAR ‐2) in relapsed/refractory mantle cell lymphoma previously treated with a covalent Bruton tyrosine kinase inhibitor. British Journal of Haematology.

MLA Style

Heß, G, et al. “A Matching‐Adjusted Indirect Comparison of Survival Outcomes with Pirtobrutinib ( BRUIN ) versus Standard of Care ( SCHOLAR ‐2) in Relapsed/Refractory Mantle Cell Lymphoma Previously Treated with a Covalent Bruton Tyrosine Kinase Inhibitor.” British Journal of Haematology, 2025.

Chicago Style

Heß, G, TA Eyre, M Jen, et al. 2025. “A Matching‐Adjusted Indirect Comparison of Survival Outcomes with Pirtobrutinib ( BRUIN ) versus Standard of Care ( SCHOLAR ‐2) in Relapsed/Refractory Mantle Cell Lymphoma Previously Treated with a Covalent Bruton Tyrosine Kinase Inhibitor.” British Journal of Haematology.
Print

Access Document

Files:: Hess_et_al_2025_A_matchingadjusted_indirect.pdf

(Preview, Version of record, pdf, 1.3MB, Terms of use)

Publisher copy:: 10.1111/bjh.70237

Authors

+ Heß, G More by this author

Role:: Author

+ Eyre, TA More by this author

Institution:: University of Oxford
Role:: Author
ORCID:: 0000-0002-6631-9749

+ Jen, M More by this author

Role:: Author

+ Zhang, J More by this author

Role:: Author

+ Goebel, B More by this author

Role:: Author

More authors...

Publisher:: Wiley
Journal:: British Journal of Haematology More from this journal
Publication date:: 2025-11-17
Acceptance date:: 2025-10-22
DOI:: 10.1111/bjh.70237
EISSN:: 1365-2141
ISSN:: 0007-1048

Language:: English
Keywords:: pirtobrutinib

relapsed/refractory mantle cell lymphoma

non‐covalent BTK inhibitor

covalent BTK inhibitor
Subtype:: Letter
Pubs id:: 2330124
UUID:: uuid_26e71335-a306-4da6-a0b4-1523677244d9
Local pid:: pubs:2330124
Source identifiers:: 3481165
Deposit date:: 2025-11-18
ARK identifier:: ark:/29072/ora_26e71335a3064da6a0b41523677244d9

Terms of use

Copyright date:: 2025

Licence:: CC Attribution (CC BY)

Views and Downloads

About views and downloads

If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP